Literature DB >> 30833496

Recalling high-strength opioid formulations would cause harm.

Kevin Wade1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30833496      PMCID： PMC6400653          DOI： 10.1503/cmaj.71587

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

Review 1.  Symptom prevalence in patients with incurable cancer: a systematic review.

Authors:  Saskia C C M Teunissen; Wendy Wesker; Cas Kruitwagen; Hanneke C J M de Haes; Emile E Voest; Alexander de Graeff
Journal:  J Pain Symptom Manage       Date:  2007-05-23       Impact factor: 3.612

2.  High-strength opioid formulations: the case for a ministerial recall.

Authors:  Matthew Herder; David Juurlink
Journal:  CMAJ       Date:  2018-12-03       Impact factor: 8.262

3.  Guideline for opioid therapy and chronic noncancer pain.

Authors:  Jason W Busse; Samantha Craigie; David N Juurlink; D Norman Buckley; Li Wang; Rachel J Couban; Thomas Agoritsas; Elie A Akl; Alonso Carrasco-Labra; Lynn Cooper; Chris Cull; Bruno R da Costa; Joseph W Frank; Gus Grant; Alfonso Iorio; Navindra Persaud; Sol Stern; Peter Tugwell; Per Olav Vandvik; Gordon H Guyatt
Journal:  CMAJ       Date:  2017-05-08       Impact factor: 8.262
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.